Haleon PLC Executes Share Buyback to Enhance Shareholder Value

Haleon PLC Sponsored ADR ( (HLN) ) has provided an announcement.

On May 30, 2025, Haleon PLC announced the purchase of 797,583 ordinary shares for cancellation as part of its share buyback program initiated on March 28, 2025. This transaction reflects Haleon’s strategic move to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation. Following this transaction, the company’s registered share capital stands at 9,006,127,704 ordinary shares, with 9,002,047,499 shares holding voting rights. This move may impact the company’s market positioning by signaling confidence in its financial health and commitment to returning value to shareholders.

The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.

Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company’s product portfolio includes six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its long-standing brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are built on trusted science, innovation, and deep human understanding.

Average Trading Volume: 14,835,949

Technical Sentiment Signal: Buy

Current Market Cap: $50.4B

For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.